Polymarket (Global)
Skin cancer vaccine BLA submitted by June 30, 2027?
June 30, 2027?
Updated 27m ago · Settles Jul 1, 27
Polymarket (Global) YES
63¢
Bid 62¢ · Ask 63¢
Pricedger fair probability
63%
Deterministic model estimate
Potential edge
+0.3 pts
On YES after fees · low confidence
Volume
52,664
Fine-print risk
52/100
Resolution-rule audit
Resolution rules — summary
This market will resolve to "Yes" if it is officially announced that a Biologics License Application (BLA) for intismeran autogene has been submitted to the U.S. Food and Drug Administration (FDA), or that the FDA has accepted such an application for review, by June 30, 2027, 11:59 PM ET. Otherwise, this market will resolve to "No". Intismeran autogene refers to the individualized neoantigen therapy developed by Mod…
Full clause-by-clause forensic audit is available inside the terminal.
Whale flow & Smart Money Divergence
See whether large traders are positioning with or against the price move on this contract.
Model ensemble & AI Deep Dive
Quant, base-rate and AI estimates compared on one scale, with clause-level fine-print analysis.
Quarter-Kelly paper sizing
Exact stake, expected value and scenario matrix for your bankroll — paper trading only.
Locked previews show illustrative sample figures.
The full Pricedger analysis is inside the terminal
Visible Ensemble consensus, AI Deep Dive with clause-by-clause fine print, whale flow and Smart Money Divergence, cross-exchange gaps, price history and quarter-Kelly paper sizing. 7-day free trial, no card required.
See the full Pricedger analysisResearch and paper trading only — not financial advice. Model estimates can be wrong. Not affiliated with Kalshi or Polymarket. Methodology